A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale
评估口服 BI 409306 治疗轻度精神病综合征的疗效、安全性和耐受性的随机 II 期试验:设计和原理
期刊:
影响因子:
doi:10.1111/eip.13083
Keefe, Richard S E; Woods, Scott W; Cannon, Tyrone D; Ruhrmann, Stephan; Mathalon, Daniel H; McGuire, Philip; Rosenbrock, Holger; Daniels, Kristen; Cotton, Daniel; Roy, Dooti; Pollentier, Stephane; Sand, Michael